Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
RaySearch Laboratories AB ( ($SE:RAY.B) ) has shared an announcement.
RaySearch Laboratories will showcase its latest radiotherapy software innovations, including RayStation, RayCare, and RayIntelligence, at the ESTRO 2026 congress in Stockholm. The company will host live product demonstrations, scientific presentations, and expert-led symposiums, reinforcing its role in shaping open, vendor-agnostic ecosystems for cancer care technology.
A central focus at ESTRO 2026 will be RaySearch’s progress in online adaptive radiotherapy, highlighted by the first patients treated using an online adaptive workflow with RayStation, RayCare, and a Varian TrueBeam system at Belgium’s Iridium Network. By enabling fast, software-driven adaptive replanning on existing linear accelerators, RaySearch aims to lower barriers for clinics adopting cutting-edge adaptive treatments and strengthen its competitive position in radiotherapy software.
More about RaySearch Laboratories AB
RaySearch Laboratories is a Stockholm-based medical technology company specializing in advanced software for cancer treatment. Its key products include the RayStation treatment planning system, the RayCare oncology information system, and the RayIntelligence analytics platform, which are used by more than 1,100 clinics in 47 countries and listed on Nasdaq Stockholm.
Average Trading Volume: 164,046
Technical Sentiment Signal: Hold
Current Market Cap: SEK6B
For detailed information about RAY.B stock, go to TipRanks’ Stock Analysis page.